Cite
Risk of Arrhythmia Among New Users of Hydroxychloroquine in Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Population‐Based Study.
MLA
Hoque, M.Rashedul, et al. “Risk of Arrhythmia Among New Users of Hydroxychloroquine in Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Population‐Based Study.” Arthritis & Rheumatology, vol. 75, no. 3, Mar. 2023, pp. 475–84. EBSCOhost, https://doi.org/10.1002/art.42337.
APA
Hoque, M. R., Lu, L., Daftarian, N., Esdaile, J. M., Xie, H., & Aviña, Z. J. A. (2023). Risk of Arrhythmia Among New Users of Hydroxychloroquine in Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Population‐Based Study. Arthritis & Rheumatology, 75(3), 475–484. https://doi.org/10.1002/art.42337
Chicago
Hoque, M. Rashedul, Leo Lu, Narsis Daftarian, John M. Esdaile, Hui Xie, and Zubieta, J. Antonio Aviña. 2023. “Risk of Arrhythmia Among New Users of Hydroxychloroquine in Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Population‐Based Study.” Arthritis & Rheumatology 75 (3): 475–84. doi:10.1002/art.42337.